AXDX - Accelerate Diagnostics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5992.19M
Enterprise Value 3987.84M
Trailing P/E N/A
Forward P/E 1-12.82
PEG Ratio (5 yr expected) 1-0.40
Price/Sales (ttm)147.34
Price/Book (mrq)38.16
Enterprise Value/Revenue 3146.69
Enterprise Value/EBITDA 6-13.47

Trading Information

Stock Price History

Beta (3Y Monthly) 3.24
52-Week Change 3-22.75%
S&P500 52-Week Change 31.35%
52 Week High 324.75
52 Week Low 310.23
50-Day Moving Average 319.04
200-Day Moving Average 319.65

Share Statistics

Avg Vol (3 month) 3185.15k
Avg Vol (10 day) 3250.73k
Shares Outstanding 554.46M
Float 27.13M
% Held by Insiders 146.20%
% Held by Institutions 150.25%
Shares Short (Jul 31, 2019) 415.66M
Short Ratio (Jul 31, 2019) 492.42
Short % of Float (Jul 31, 2019) 449.93%
Short % of Shares Outstanding (Jul 31, 2019) 428.73%
Shares Short (prior month Jun 28, 2019) 415.46M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-1,129.14%

Management Effectiveness

Return on Assets (ttm)-25.22%
Return on Equity (ttm)-143.64%

Income Statement

Revenue (ttm)6.73M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)6.70%
Gross Profit (ttm)2.48M
EBITDA -73.32M
Net Income Avi to Common (ttm)-86.83M
Diluted EPS (ttm)-1.60
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)137.82M
Total Cash Per Share (mrq)2.53
Total Debt (mrq)125.29M
Total Debt/Equity (mrq)481.80
Current Ratio (mrq)19.99
Book Value Per Share (mrq)0.48

Cash Flow Statement

Operating Cash Flow (ttm)-65.9M
Levered Free Cash Flow (ttm)-30.34M